Improving Walking After a Lower Limb Injury Using a Custom Motorized Orthosis

August 25, 2025 updated by: Karen J. Nolan, PhD, Kessler Foundation

Individualizing Powered Orthotic Intervention for Improved Gait Outcomes Using ML-enabled Methods

The purpose of this research study is to assess the ease, convenience, and efficacy of walking when using a motor powered ankle foot orthosis (AFO) brace, in adults who have had a lower limb injury.

Study Overview

Status

Recruiting

Conditions

Detailed Description

The long-term goal of this project is to improve the outcomes of robot-assisted exercise interventions for patients with reconstructed lower limb following high-energy lower extremity traumas using novel machine learning methods to enable individualized ankle foot orthosis (AFO) designs and self-adaptive AFO assistance.

The main hypothesis predicts greater comfort and lower pain levels when using the new AFO as well as improvements in gait mechanics, which will outperform those induced by patients' daily-use AFOs. The main goal is this adaptive assistance will encourage the wearer's active engagement in RAGT thereby promoting patient self-efficacy/satisfaction and leading to improvements in ambulation after a 6-week rehabilitation program.

Study Type

Interventional

Enrollment (Estimated)

19

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Have a lower limb injury greater than a year ago.
  • Be 18-80 years old.
  • Be able to stand for 30 minutes.
  • Have enough range of motion in my ankle to comfortably wear the AFO.
  • Be able to follow directions and commands.
  • Be willing and able to give informed consent.
  • Be able and willing to comply with study procedures, verbal instructions, and follow-up requirements.

Exclusion Criteria:

  • Have any joint or muscle tightness that would limit my movement while walking with the AFO.
  • Have any medical issue that prevents me from supporting my weight and walking (e.g. orthopedic injuries, pain, severe spasticity).
  • Have any medical issues that affect my unaffected side.
  • Have skin issues that would prevent wearing the device.
  • Have a pre-existing condition that caused exercise intolerance. (Documented uncontrolled hypertension, coronary artery disease, abnormal heart rate or rhythm, or congestive heart failure).
  • Have been hospitalized for heart attack, heart surgery or acute heart failure within 3 months of enrollment in study.
  • Have nervous system issues that affect my movement (for example Parkinson's disease, multiple sclerosis).
  • Have additional orthopedic issues that interfere with my walking or limit my range of motion in my legs.
  • Have any other medical conditions that my doctor or physical therapist feels would affect my ability to use the device.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Adults with lower limb injury
All enrolled subjects will be asked to complete the intervention.
While part of this study, participants will be fitted for the motorized orthosis and will complete walking tests with and without the AFO.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
10MWT (Aim 1)
Time Frame: Measured before and after 6 week intervention to assess change from baseline.
10 meter walk test to evaluate walking speed after lower limb injury and in response to the intervention. Walking evaluated without versus with the motorized orthosis.
Measured before and after 6 week intervention to assess change from baseline.
TUG (Aim 1)
Time Frame: Measured before and after 6 week intervention to assess change from baseline.
Timed up and go (TUG) test to measure functional balance and walking ability after lower limb injury and in response to the intervention. Walking evaluated without versus with the motorized orthosis.
Measured before and after 6 week intervention to assess change from baseline.
6MWT (Aim 1)
Time Frame: Measured before and after 6 week intervention to assess change from baseline.
6 minute walking test to evaluate endurance after lower limb injury and in response to the intervention. Walking evaluated without versus with the motorized orthosis.
Measured before and after 6 week intervention to assess change from baseline.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2025

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

June 1, 2027

Study Registration Dates

First Submitted

April 2, 2025

First Submitted That Met QC Criteria

April 9, 2025

First Posted (Actual)

April 11, 2025

Study Record Updates

Last Update Posted (Estimated)

August 26, 2025

Last Update Submitted That Met QC Criteria

August 25, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • D-1182-22

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lower Limb Injury

Clinical Trials on Utilization of motorized orthosis

Subscribe